Early Labs vs Nucleix
Early Labs vs Nucleix, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Early Labs is on 43/100 and Nucleix on 56/100.
Where each one leads
Early Labs
Leads on none of the measures we hold for both companies.
Nucleix
- our overall score: 56/100 against 43/100
- domain rating: 38/100 against 2/100
- headcount: 74 against 7
- headcount growth: +7.1% against -5.0%
At a glance
| Measure | Early Labs | Nucleix |
|---|---|---|
| What it is | Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations. | Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis. |
| Category | Healthcare, Oncology, Detection, Urine | Healthcare, Lung, Bladder, Cancer |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2017 | 2008 |
| Headquarters | Tel Aviv, Israel | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Early Labs | Nucleix |
|---|---|---|
| Employees | 7 | 74 |
| Headcount growthLast 12 months | -5.0% | +7.1% |
| Total funding | Not published | $88.0M |
| Latest round | Not published | Funding Round |
| LinkedIn followers | Not published | 7,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Early Labs | Nucleix |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 56/100 |
| Traction | 9/100 | 59/100 |
| Team | 60/100 | 70/100 |
| Search visibility | 8/100 | 36/100 |
| Quality | 58/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 2/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Early Labs | Nucleix |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Not detected | Google Analytics 4 |
What users say
| Measure | Early Labs | Nucleix |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.”r/LungCancerSupport
Early Labs vs Nucleix: common questions
Which is better, Early Labs or Nucleix?
On our 0-100 score Nucleix rates higher (56/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Early Labs and Nucleix compare on the numbers?
Nucleix leads on our overall score (56/100 against 43/100), domain rating (38/100 against 2/100), headcount (74 against 7), headcount growth (+7.1% against -5.0%).
What do real users say about Early Labs and Nucleix?
Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.
Read the full Early Labs review and pricing or the Nucleix review and pricing. You can also browse other Early Labs alternatives we track.